What is ITF Pharma?
Founded in 1938 and headquartered in Milan, Italy, Italfarmaco SpA operates as a private multinational pharmaceutical powerhouse. The company specializes in the research, development, and manufacturing of both prescription and over-the-counter therapeutic solutions. With a core mission centered on disease prevention and management, ITF Pharma has carved out a niche in the development of treatments for rare diseases. By leveraging decades of scientific expertise, the firm bridges the gap between laboratory innovation and patient-centric healthcare, ensuring that high-quality medical interventions remain accessible to diverse global populations.
How much funding has ITF Pharma raised?
ITF Pharma has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in ITF Pharma
PPP
Public-Private Partnership
What's next for ITF Pharma?
With this late-stage funding, ITF Pharma is well-positioned to accelerate its R&D initiatives and scale its commercial operations. The strategic allocation of these resources will likely focus on deepening the company's rare disease portfolio and enhancing its manufacturing capabilities to meet rising international demand. As the pharmaceutical landscape shifts toward personalized medicine and targeted therapies, ITF Pharma's robust foundation provides a stable platform for long-term growth and continued scientific breakthroughs in therapeutic areas that remain underserved by traditional market players.
See full ITF Pharma company page
